Literature DB >> 28511382

Rapid Identification of Vancomycin Resistant Enterococcus Faecalis Clinical Isolates using a Sugar Fermentation Method.

Javad Raeisi1, Mahnaz Saifi2, Mohammad Reza Pourshafie3, Mehri Habibi4, Hamid Reza Mohajerani5, Neda Akbari5, Mohammad Reza Asadi Karam4.   

Abstract

INTRODUCTION: Vancomycin Resistant Enterococci (VRE) can be found all over the world. Thus, rapid detection of the isolates could be of high importance in the treatment or prevention of the associated disease. AIM: To measure the turanose fermentation in Enterococcus faecalis clinical isolates for rapid differentiation of VRE and Vancomycin-Susceptible E. faecalis (VSE) isolates.
MATERIALS AND METHODS: Forty E. faecalis samples were isolated from 200 clinical samples in Tehran Medical Center, Iran, from October 2012 to December 2012. These isolates were detected according to the standard microbial and biochemical tests. Detection of VRE isolates was originally performed by disk diffusion using 1 μg vancomycin disk, followed by Polymerase Chain Reaction (PCR) amplification of the vanA gene. Finally, the turanose consumption in 1%, 0.7% and 0.5% dilutions was detected by a phenotypic method.
RESULTS: Among the 40 E. faecalis isolates, 20 vancomycin-susceptible and 20 vancomycin-resistant E. faecalis were isolated according to the disk diffusion and PCR of the vanA gene. There was a considerable difference between VRE and VSE isolates in 0.7% dilution of turanose. However, there was no significant difference between VRE and VSE in 1% and 0.5% dilutions of turanose.
CONCLUSION: Since detection of VRE isolates is of high importance, especially in nosocomial infections, phenotypic methods may be highly useful for this purpose. In conclusion, our data indicate that VRE isolated from clinical samples could be distinguished from VSE isolates by turanose fermentation at dilution 0.7%.

Entities:  

Keywords:  Antibiotic resistance; Phenotypic methods; Turanose consumption

Year:  2017        PMID: 28511382      PMCID: PMC5427308          DOI: 10.7860/JCDR/2017/19017.9568

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  33 in total

Review 1.  Current concepts in laboratory testing to guide antimicrobial therapy.

Authors:  Stephen G Jenkins; Audrey N Schuetz
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

Review 2.  The rise of the Enterococcus: beyond vancomycin resistance.

Authors:  Cesar A Arias; Barbara E Murray
Journal:  Nat Rev Microbiol       Date:  2012-03-16       Impact factor: 60.633

3.  Molecular characterization of resistance, virulence and clonality in vancomycin-resistant Enterococcus faecium and Enterococcus faecalis: A hospital-based study in Beijing, China.

Authors:  Jing-xian Yang; Tong Li; Yong-zhong Ning; Dong-hua Shao; Jing Liu; Shu-qin Wang; Guo-wei Liang
Journal:  Infect Genet Evol       Date:  2015-05-12       Impact factor: 3.342

Review 4.  The emergence and evolution of methicillin-resistant Staphylococcus aureus.

Authors:  K Hiramatsu; L Cui; M Kuroda; T Ito
Journal:  Trends Microbiol       Date:  2001-10       Impact factor: 17.079

5.  Vancomycin-resistant enterococci among haemodialysis patients in Portugal: prevalence and molecular characterization of resistance, virulence and clonality.

Authors:  Susana Correia; Pedro Ponce; Daniela Jones-Dias; Manuela Caniça; Gilberto Igrejas; Patrícia Poeta
Journal:  Enferm Infecc Microbiol Clin       Date:  2013-10-27       Impact factor: 1.731

Review 6.  Vaccination and passive immunisation against Staphylococcus aureus.

Authors:  Adam C Schaffer; Jean C Lee
Journal:  Int J Antimicrob Agents       Date:  2008-08-30       Impact factor: 5.283

7.  Evaluation of genetically inactivated alpha toxin for protection in multiple mouse models of Staphylococcus aureus infection.

Authors:  Rebecca A Brady; Christopher P Mocca; Ranjani Prabhakara; Roger D Plaut; Mark E Shirtliff; Tod J Merkel; Drusilla L Burns
Journal:  PLoS One       Date:  2013-04-29       Impact factor: 3.240

8.  Microevolutionary events involving narrow host plasmids influences local fixation of vancomycin-resistance in Enterococcus populations.

Authors:  Ana R Freitas; Carla Novais; Ana P Tedim; María Victoria Francia; Fernando Baquero; Luísa Peixe; Teresa M Coque
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

9.  Genomic insights to control the emergence of vancomycin-resistant enterococci.

Authors:  Benjamin P Howden; Kathryn E Holt; Margaret M C Lam; Torsten Seemann; Susan Ballard; Geoffrey W Coombs; Steven Y C Tong; M Lindsay Grayson; Paul D R Johnson; Timothy P Stinear
Journal:  mBio       Date:  2013-08-13       Impact factor: 7.867

Review 10.  Recurrent Challenges for Clinicians: Emergence of Methicillin-Resistant Staphylococcus aureus, Vancomycin Resistance, and Current Treatment Options.

Authors:  Bansidhar Tarai; Poonam Das; Dilip Kumar
Journal:  J Lab Physicians       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.